Current studies

KIDNEY DISEASE STUDIES -

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease (APPRECIATE)

ClinicalTrials.gov ID NCT06824987

https://clinicaltrials.gov/study/NCT06824987?cond=Chronic%20Kidney%20Disease&term=NCT06824987&aggFilters=status:not%20rec&limit=10&sort=@relevance&rank=1

A Study to Test Whether Vicadrostat in Combination With Empagliflozin (Simultaneous vs. Staggered Initiation) Helps People With Chronic Kidney Disease (EASi-SYNC)

ClinicalTrials.gov ID NCT06926660. 

https://clinicaltrials.gov/study/NCT06926660?cond=Chronic%20Kidney%20Disease&term=NCT06926660&aggFilters=status:not%20rec&limit=10&sort=@relevance&rank=1

CARDIOVASCULAR RISK DISEASE STUDY -

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) (MOVE-Lp(a))

ClinicalTrials.gov ID NCT07157774

https://clinicaltrials.gov/study/NCT07157774?cond=LPA&term=MOVE-Lp(a)&rank=1&tab=study

Check back here regularly for the latest trials going on at Masters of Clinical Research, Inc...

If you are interested in participating or want more information please call 706-210-8890.